| Cash Flow | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|
| Net loss for the period | -689,712 | -84,660 | -551,294 |
| Amortization of debt discount (non-cash) | 108,092 | - | - |
| (gain) loss on change in fair value of derivative liability (non-cash) | -17,816 | - | - |
| Impairment loss | - | - | 300,000 |
| Loss on issuance of convertible notes and commitment shares (non-cash) | 238,347 | - | - |
| Gain on sale of property, plant and equipment | - | - | 10,518 |
| Lender legal and transaction costs (non-cash - withheld at closing) | 11,030 | - | - |
| Credit loss on account receivables and other non current asset | - | - | 95,747 |
| Subscription money advance | -55,000 | - | - |
| Shares issued for services availed | - | - | 27,463 |
| Trade payable | 80,711 | - | - |
| Trade receivable | 0 | - | 52,288 |
| Accounts payable and accrued liabilities | - | - | -145,168 |
| Subscription money advance | - | 199,979 | - |
| Intercompany balances | 0 | - | - |
| Net cash provided by (used in) operating activities | -414,327 | 115,319 | -336,057 |
| Investment in subsidiary | 0 | - | - |
| Proceeds from disposal of unproved properties | - | - | 10,518 |
| Purchase of plant and equipment | 163,776 | - | - |
| Net cash provided by (used in) investing activities | -163,776 | - | 10,518 |
| Proceeds from issuance of convertible notes, net of costs withheld | 252,970 | - | - |
| Proceeds from issuance of common stock | 244,308 | - | 63,001 |
| Subscriptions received for common stock pending issuance | - | - | 105,941 |
| Net cash provided by (used in) financing activities | 497,278 | - | 168,941 |
| Net increase (decrease) in cash and cash equivalents | -80,824 | 115,319 | -156,598 |
| Cash and cash equivalents at january 1, | 134,736 | 19,417 | 176,016 |
| Cash and cash equivalents at june 30, | 53,912 | 134,736 | 19,417 |
HyOrc Corp (HYOR)
HyOrc Corp (HYOR)